from the fear-or-no-fear-nanotech-still-gets-funded dept.
According to John Ellis of Fast Company (Dec. 2001): "Before September 11, the debate among business and financial strategists was, roughly stated, nanotechnology versus genomics/proteomics. Which will be the next big thing? Where would you put your money? The best minds at Goldman Sachs, Merrill Lynch, Morgan Stanley, and Citigroup wrestled with these questions, as did those at the country's venture firms." After Sept. 11: "[The Age of Fear] means that a whole host of new technologies — like nanotechnology — will get more funding from the federal government."
This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.